NIH/NCI: R01 (PI: Masamha, C.P.): Title: Elucidating the mechanism and consequences of aberrant cyclin D1 gene expression (submitted on October 2019).

Report of invention (no. 67383-01): Biomarkers for early detection of hepatocellular carcinoma (HCC). Stefanska B (Purdue University, 2016, provisional application for patent submitted)

Tao, W. A., Ilyuk, A. B., Andaluz, H., Chen, I. H., & Pan, L. (2018). U.S. Patent Application No. 15/864,376.